Latest International Development News

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Wrkr Ltd reported a 10.8% revenue increase to $10.63 million and narrowed its net loss to $2.62 million for FY2025, while securing $15 million in fresh capital to accelerate growth amid upcoming PayDay Super reforms.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

Syrah Resources’ Mozambican graphite operation receives a $6.5 million loan disbursement from the US DFC, with further funding contingent on a critical loan restructure planned for September.

Opthea has successfully settled its Development Funding Agreement, avoiding a potential $680 million liability and securing $20 million in cash. Leadership changes include the CEO and CFO stepping down, with the Chairman assuming CEO duties.

Adrad Holdings reported an 8.9% rise in FY25 sales revenue to $153.1 million despite a slight dip in EBITDA, while declaring a fully franked dividend and outlining strategic initiatives for FY26.

Wrkr Limited is raising approximately A$15 million through an institutional placement to accelerate growth amid upcoming Payday Super reforms and market opportunities.

Wrkr Ltd has completed a $15 million placement to fund key growth initiatives and compliance upgrades ahead of new superannuation regulations.

Syrah Resources has initiated a fully underwritten A$70 million equity raising alongside a two-year forbearance agreement with the US Department of Energy, supporting its Vidalia and Balama operations. The retail entitlement offer opened on 6 August and closes on 20 August 2025.

Alkane Resources has received final court approval to acquire Mandalay Resources, setting the stage for a transformative merger expected to complete on August 5, 2025.

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.